IL99011A0 - 2-(9-fluorenonyl)-carbapenems and pharmaceutical compositions containing them - Google Patents
2-(9-fluorenonyl)-carbapenems and pharmaceutical compositions containing themInfo
- Publication number
- IL99011A0 IL99011A0 IL99011A IL9901191A IL99011A0 IL 99011 A0 IL99011 A0 IL 99011A0 IL 99011 A IL99011 A IL 99011A IL 9901191 A IL9901191 A IL 9901191A IL 99011 A0 IL99011 A0 IL 99011A0
- Authority
- IL
- Israel
- Prior art keywords
- fluorenonyl
- carbapenems
- pharmaceutical compositions
- compositions containing
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/561,541 US5025007A (en) | 1990-08-01 | 1990-08-01 | 2-(9-fluorenonyl)-carbapenem antibacterial agents |
| US07/594,809 US5144028A (en) | 1990-10-09 | 1990-10-09 | 2-(9-fluorenonyl)-carbapenem intermediates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL99011A0 true IL99011A0 (en) | 1992-07-15 |
Family
ID=27072673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL99011A IL99011A0 (en) | 1990-08-01 | 1991-07-30 | 2-(9-fluorenonyl)-carbapenems and pharmaceutical compositions containing them |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0469844A1 (xx) |
| JP (1) | JPH0798821B2 (xx) |
| KR (1) | KR920004389A (xx) |
| AU (1) | AU643308B2 (xx) |
| CA (1) | CA2048279A1 (xx) |
| FI (1) | FI913654A (xx) |
| IE (1) | IE912708A1 (xx) |
| IL (1) | IL99011A0 (xx) |
| MX (1) | MX9100467A (xx) |
| NO (1) | NO912979L (xx) |
| NZ (1) | NZ239187A (xx) |
| PT (1) | PT98521A (xx) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2142735A1 (en) * | 1993-06-18 | 1995-01-05 | Tatsuyoshi Tanaka | Fluorenone derivatives, process for preparing the same and central or peripheral nerve degeneration repair and protective agent |
| US5451579A (en) * | 1994-02-15 | 1995-09-19 | Merck & Co., Inc. | 1-β-methyl-carbapenem, compositions containing same and methods of use |
| EP1785426A4 (en) * | 2004-09-03 | 2008-02-20 | Dainippon Sumitomo Pharma Co | NEW CARBAPENEM DERIVATIVE |
| EP2135871A1 (en) * | 2008-06-18 | 2009-12-23 | LEK Pharmaceuticals D.D. | New trinem antibiotics and inhibitors of beta-lactamases |
| NZ603186A (en) | 2010-07-08 | 2014-04-30 | Hans Rudolf Pfaendler | Fluorescent carbapenems |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4543257A (en) * | 1977-10-19 | 1985-09-24 | Merck & Co., Inc. | 1-Carba-2-penem-3-carboxylic acid |
| US4260627A (en) * | 1978-10-24 | 1981-04-07 | Merck & Co., Inc. | 1-, 6- And 2-substituted-1-carba-2-penem-3-carboxylic acids |
| US4600713A (en) * | 1979-12-03 | 1986-07-15 | Merck & Co., Inc. | 1-, 6- and 2-substituted-1-carba-2-penem-3-carboxylic acids |
| EP0277743A1 (en) * | 1987-02-02 | 1988-08-10 | Merck & Co. Inc. | 2-(heteroaryliumalkyl)phenyl carbapenem antibacterial agents |
| US5025008A (en) * | 1989-06-08 | 1991-06-18 | Merck & Co., Inc. | 2-(substituted-dibenzofuranyl and dibenzothienyl) carbapenem antibacterial agents |
-
1991
- 1991-07-30 IL IL99011A patent/IL99011A0/xx unknown
- 1991-07-30 EP EP91306954A patent/EP0469844A1/en not_active Ceased
- 1991-07-30 NZ NZ239187A patent/NZ239187A/xx unknown
- 1991-07-31 PT PT98521A patent/PT98521A/pt not_active Application Discontinuation
- 1991-07-31 NO NO91912979A patent/NO912979L/no unknown
- 1991-07-31 AU AU81518/91A patent/AU643308B2/en not_active Ceased
- 1991-07-31 KR KR1019910013162A patent/KR920004389A/ko not_active Application Discontinuation
- 1991-07-31 JP JP3280912A patent/JPH0798821B2/ja not_active Expired - Lifetime
- 1991-07-31 MX MX9100467A patent/MX9100467A/es unknown
- 1991-07-31 IE IE270891A patent/IE912708A1/en unknown
- 1991-07-31 FI FI913654A patent/FI913654A/fi not_active Application Discontinuation
- 1991-08-01 CA CA002048279A patent/CA2048279A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NZ239187A (en) | 1993-10-26 |
| NO912979D0 (no) | 1991-07-31 |
| AU643308B2 (en) | 1993-11-11 |
| MX9100467A (es) | 1992-04-01 |
| EP0469844A1 (en) | 1992-02-05 |
| FI913654A0 (fi) | 1991-07-31 |
| PT98521A (pt) | 1992-06-30 |
| KR920004389A (ko) | 1992-03-27 |
| JPH05105681A (ja) | 1993-04-27 |
| CA2048279A1 (en) | 1992-02-02 |
| AU8151891A (en) | 1992-02-06 |
| NO912979L (no) | 1992-02-03 |
| FI913654A (fi) | 1992-02-02 |
| JPH0798821B2 (ja) | 1995-10-25 |
| IE912708A1 (en) | 1992-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2251791B (en) | Pharmaceutical compositions containing benzenesulphonamides | |
| NZ244766A (en) | Bi-aromatic compounds and pharmaceutical compositions | |
| IL97122A0 (en) | Aromatase-inhibiting androstendiones and pharmaceutical compositions containing them | |
| GB9115893D0 (en) | Pharmaceutical compositions | |
| GB9011767D0 (en) | Pharmaceutical compositions | |
| GB9122083D0 (en) | Pharmaceutical compositions | |
| NZ239483A (en) | Phosphonopyrrolidine or -piperidine derivatives and pharmaceutical compositions | |
| ZA911065B (en) | Chemical and pharmaceutical compositions | |
| IL98911A0 (en) | 2-(9-fluorenonyl)-carbapenems and pharmaceutical compositions containing them | |
| IL99011A0 (en) | 2-(9-fluorenonyl)-carbapenems and pharmaceutical compositions containing them | |
| GB9026080D0 (en) | Pharmaceutical compositions | |
| IL104120A0 (en) | Novel thiazoles and pharmaceutical compositions containing them | |
| GB9003185D0 (en) | Pharmaceutical compositions | |
| GB9115156D0 (en) | Pharmaceutical compositions | |
| ZA915450B (en) | Pharmaceutical composition | |
| IL94658A0 (en) | 1,5-diazabicyclodiones and pharmaceutical compositions containing them | |
| GB9015418D0 (en) | Pharmaceutical compositions | |
| IL93286A0 (en) | Pharmaceutical compositions comprising arylalkyl-amines and-amides and certain such novel compounds | |
| HU9803012D0 (en) | N-cycloalkyl-amine-derivatives and pharmaceutical compositions containing the same | |
| GB9018194D0 (en) | Pharmaceutical composition | |
| GB9016176D0 (en) | Pharmaceutical composition | |
| ZA911438B (en) | Pharmaceutical composition | |
| GB9002350D0 (en) | Pharmaceutical composition | |
| GB9005599D0 (en) | Pharmaceutical composition | |
| GB9011541D0 (en) | Pharmaceutical composition |